The BRCA2 mutation status shapes the immune phenotype of prostate cancer
2019 · Cancer Immunology Immunotherapy · 52 citations
https://doi.org/10.1007/s00262-019-02393-x
C
Cathleen Nientiedt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
425
Citations
10
h-index
11
i10-index
Cathleen Nientiedt is an academic researcher from University of Freiburg. The author has contributed to research in topics: Prostate Cancer Treatment and Research & PARP inhibition in cancer therapy & Cancer Genomics and Diagnostics. The author has an h-index of 10, co-authored 18 publications.
ORCID: 0000-0001-5970-5951Papers by this author
worksGenomic features of renal cell carcinoma with venous tumor thrombus
2018 · Scientific Reports · 31 citations
https://doi.org/10.1038/s41598-018-25544-z
Supplementary Material for: Senescent tumor cells are frequently present at the invasion front - implications for improving disease control in patients with locally advanced prostate cancer
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22434493
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat